DNASE1L3 and hepatocellular carcinoma: To further verify this hypothesis, RNA-seq analysis was conducted on sorafenib-treated LV-D and LV-veh MHCC97-H HCC cells, revealing a significant inhibition of the cellular nucleosome repair pathway upon DNASE1L3 overexpression (Figure 4C).